<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>International | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/international/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Fri, 14 Aug 2026 18:53:56 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>International | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board</title>
		<link>https://tissuepathology.com/2026/08/14/global-leader-in-digital-pathology-ai-healthcare-aetherai-7803-officially-lists-on-the-taiwan-innovation-board/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 14 Aug 2026 18:53:56 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[aetherAI]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Hardware]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Software]]></category>
		<category><![CDATA[Taiwan Innovation Board]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24617</guid>

					<description><![CDATA[<p>aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare solutions, officially began trading on the Taiwan Innovation Board on May 20 at an offering price of NT$23.12 per share. A listing ceremony and opening [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/14/global-leader-in-digital-pathology-ai-healthcare-aetherai-7803-officially-lists-on-the-taiwan-innovation-board/">Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite</title>
		<link>https://tissuepathology.com/2026/08/05/aiforia-unlocking-diagnostic-value-at-fimlab-with-aiforia-breast-cancer-suite/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 05 Aug 2026 13:12:53 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Aiforia]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Fimlab]]></category>
		<category><![CDATA[Finland]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Philips]]></category>
		<category><![CDATA[Softwarepoint]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24593</guid>

					<description><![CDATA[<p>From the Aiforia blog: In modern clinical pathology, adopting artificial intelligence (AI) is no longer just about algorithm accuracy. A key success factor is seamless workflow integration. Pathology departments manage high sample volumes under strict turnaround times, with vendor lock-in and fragmented software as major obstacles to scaling their digital pathology workflows. Last June, at [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/05/aiforia-unlocking-diagnostic-value-at-fimlab-with-aiforia-breast-cancer-suite/">Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lumea Receives Global Recognition Award for Exceptional Achievement</title>
		<link>https://tissuepathology.com/2026/07/28/lumea-receives-global-recognition-award-for-exceptional-achievement/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 28 Jul 2026 12:50:34 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Global Recognition Award]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lumea]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24575</guid>

					<description><![CDATA[<p>From the Lumea blog: We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team and the countless hours they’ve put into revolutionizing cancer diagnostics and digital pathology by raising the standard for tissue quality with our software [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/28/lumea-receives-global-recognition-award-for-exceptional-achievement/">Lumea Receives Global Recognition Award for Exceptional Achievement</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aiforia brings AI-assisted lung cancer analysis to NHS pathology workflows</title>
		<link>https://tissuepathology.com/2026/07/27/aiforia-brings-ai-assisted-lung-cancer-analysis-to-nhs-pathology-workflows/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 27 Jul 2026 12:13:32 +0000</pubDate>
				<category><![CDATA[Anatomic Pathology]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Aiforia]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Microsoft]]></category>
		<category><![CDATA[Microsoft Azure]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[University Hospital Southampton NHS Foundation Trust]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24573</guid>

					<description><![CDATA[<p>Aiforia is helping University Hospital Southampton NHS Foundation Trust support faster, more consistent pathology workflows on Microsoft Azure through AI-assisted lung cancer analysis. For years, the promise of AI has been to empower people to work more efficiently, make better decisions, and focus attention where it matters most. In healthcare, that promise carries particular weight. [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/27/aiforia-brings-ai-assisted-lung-cancer-analysis-to-nhs-pathology-workflows/">Aiforia brings AI-assisted lung cancer analysis to NHS pathology workflows</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics</title>
		<link>https://tissuepathology.com/2026/07/24/ibex-medical-analytics-achieves-ce-ivdr-certification-for-breast-panel-ihcs-elevating-the-standard-of-care-in-ai-powered-breast-cancer-diagnostics/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 24 Jul 2026 12:06:23 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Breast Panel IHCs]]></category>
		<category><![CDATA[CE IVDR certification]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Ibex Medical Analytics]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24570</guid>

					<description><![CDATA[<p>Ibex: The clinical validation and regulatory certification of Ibex&#8217;s breast IHC workflow is expected to further boost pathology lab performance and enhance patient care BOSTON &#38; TEL AVIV, Israel&#8211;(BUSINESS WIRE)&#8211;Ibex Medical Analytics (Ibex), the global leader in AI-powered pathology solutions for clinical diagnostics and biopharma, today announced that it has received In Vitro Diagnostic Medical [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/24/ibex-medical-analytics-achieves-ce-ivdr-certification-for-breast-panel-ihcs-elevating-the-standard-of-care-in-ai-powered-breast-cancer-diagnostics/">Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform</title>
		<link>https://tissuepathology.com/2026/07/22/techcyte-marks-11-million-ai-assisted-scans-across-its-global-platform/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 22 Jul 2026 12:13:49 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[Techcyte]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24566</guid>

					<description><![CDATA[<p>OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ &#8212; Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer environments spanning human, veterinary, and environmental diagnostic platforms. The milestone marks a significant step in the company&#8217;s mission to make AI-driven diagnostics accessible to [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/22/techcyte-marks-11-million-ai-assisted-scans-across-its-global-platform/">Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
